Christopher P. Lowe - Interim CEO, COO & CFO at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CEO, COO & CFO
Stock Symbol
QNCX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher P. Lowe since 10/6/2023

Holdings reported by Christopher P. Lowe for Quince Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 265K $249K $0.94 Mar 3, 2022 Direct

Transactions reported by Christopher P. Lowe for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.